Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucose 40% oral gel
0601040I0AAADAD
|
Glucose (Hypoglycaemia) | Glucose | Endocrine System | 40,223 |
|
GlucoGel 40% gel original
0601040I0BBABAD
|
GlucoGel | Glucose | Endocrine System | 31,867 |
|
Dextrogel 40% gel
0601040I0BEAAAD
|
Dextrogel | Glucose | Endocrine System | 5,276 |
|
Rapilose 40% gel
0601040I0BFAAAD
|
Rapilose | Glucose | Endocrine System | 2,995 |
|
YourGLUCO 40% gel
0601040I0BHAAAD
|
YourGLUCO | Glucose | Endocrine System | 1,549 |
|
GlucoBoost 40% gel
0601040I0BGAAAD
|
GlucoBoost | Glucose | Endocrine System | 488 |
|
GlucoGel 40% gel berry
0601040I0BBAEAD
|
GlucoGel | Glucose | Endocrine System | 173 |
|
GSF-Syrup oral gel 18g sachets mixed
0601040I0BDABAG
|
GSF-Syrup | Glucose | Endocrine System | 112 |
|
GSF-Syrup oral gel 18g sachets orange
0601040I0BDACAG
|
GSF-Syrup | Glucose | Endocrine System | 55 |
|
Rapilose OGTT solution
0601040I0BFABAE
|
Rapilose | Glucose | Endocrine System | 54 |
|
GSF-Syrup oral gel 18g sachets tropical
0601040I0BDADAG
|
GSF-Syrup | Glucose | Endocrine System | 24 |
|
GSF-Syrup oral gel 18g sachets peppermint
0601040I0BDAAAG
|
GSF-Syrup | Glucose | Endocrine System | 14 |
|
Glucose 5% infusion 1litre
0902021G0AABDBD
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | 4 |
|
Glucose 5% infusion 500ml
0902021G0AABCBC
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | 4 |
|
Glucose 5% infusion 100ml bags
0902021G0AAA3A3
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | 1 |
|
Glucose 5% infusion 50ml bags
0902021G0AABGBG
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | 1 |
|
Glucose 5% infusion 50ml Viaflex bags
0902021G0BBAGBG
|
Baxter glucose | Glucose | Nutrition and Blood | 1 |
|
Glucose 50% solution for infusion 50ml vials
0902021G0AAAQAQ
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | 1 |
|
Polyfusor D glucose 5% infusion 500ml bottles
0902021G0BEACBC
|
Polyfusor glucose | Glucose | Nutrition and Blood | 1 |
|
AACE Gluco 40% gel
0601040I0BKAAAD
|
AACE Gluco | Glucose | Endocrine System | No data available |
|
AddGluco 40% gel
0601040I0BJAAAD
|
AddGluco | Glucose | Endocrine System | No data available |
|
Clintec glucose 20% infusion 500ml bags
0902021G0BDAABB
|
Clintec glucose | Glucose | Nutrition and Blood | No data available |
|
Clintec glucose 50% infusion 500ml bags
0902021G0BDABAY
|
Clintec glucose | Glucose | Nutrition and Blood | No data available |
|
Generic GSF-Syrup oral gel 18g sachets
0601040I0AAAGAG
|
Glucose (Hypoglycaemia) | Glucose | Endocrine System | No data available |
|
Generic TRUEplus oral gel
0601040I0AAAHAH
|
Glucose (Hypoglycaemia) | Glucose | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.